Besides, the inhibition of MKP-1 also promoted gemcitabine sensitivity in pancreatic cancer [18], dexamethasone sensitivity in lung cancer [19], and the sensitivities of three chemotherapy drugs (mechlorethamine, doxorubicin, and paclitaxel) in breast cancer [20]. This evidence concerns the gene DUSP1 and lung carcinoma.